Asset Management

Australia's Challenger lays down the gauntlet in Europe with Dexion deal

The A$60 billion investment manager is aiming to replicate its multi-boutique model in Europe after the £19.6 million alternatives acquisition

Dexion Capital founder Robin Bowie: Deal is "very attractive to both investors and managers"
Dexion Capital founder Robin Bowie: Deal is "very attractive to both investors and managers"

The boutique fund management arm of listed Australian manager Challenger has bought UK-based alternatives group Dexion Capital, in a move that “substantially expands” its presence in Europe.

Fidante Partners, the boutique funds unit of A$60.4 billion (£28.9 billion) investment manager Challenger, hopes the deal will enable it to bring its "multi-boutique model" to Europe, using Dexion's distribution channels to boost its UK operations, according to a Challenger statement on Wednesday.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump